Enforcement of the Hatch Act, which restricts the political activity of government workers, has historically been weak against high-ranking officials.

A potent mix of bureaucratic red tape and adverse court rulings is deterring U.S. startups and small businesses from ...

The Federal Circuit heard oral argument in Auribundo's appeal of the district court's decision in favor of plaintiff Merck, ...

With the recent convocation of the 119th Congress, a change in administration, and resignation of USPTO Director Vidal, pharmaceutical patent ...

The Patent Eligibility Restoration Act (PERA) proposes a solution to a complex debate: What can be patented, and when do ...

SOUTH SAN FRANCISCO, Calif. - Quince Therapeutics, Inc. (NASDAQ: QNCX), a biotech firm focusing on rare diseases with a current market capitalization of $67.76 million, has received a Notice of ...

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s ...

This will provide Quince notice of future generic applicants and give the company other stay provisions under applicable provisions of the Hatch-Waxman Act. This protection is in addition to the ...

"We are dedicated to supporting parties involved in ANDA litigation," said WIT's Hatch-Waxman Chair Michael Crowe. "Our team has worked with hundreds of testifying experts in cases before district ...